Bausch Health Cos Other Current Assets 2010-2024 | BHC

Bausch Health Cos other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bausch Health Cos Annual Other Current Assets
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $261
2015 $3
2014 $
2013 $16
2012 $91
2011 $72
2010 $4
2009 $9
Bausch Health Cos Quarterly Other Current Assets
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30 $16
2017-06-30 $77
2017-03-31 $240
2016-12-31 $261
2016-09-30
2016-06-30
2016-03-31
2015-12-31 $3
2015-09-30
2015-06-30
2015-03-31 $8
2014-12-31
2014-09-30 $10
2014-06-30 $1,157
2014-03-31 $29
2013-12-31 $16
2013-09-30 $53
2013-06-30 $54
2013-03-31 $57
2012-12-31 $91
2012-09-30 $10
2012-06-30 $28
2012-03-31 $3
2011-12-31 $72
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $7
2010-03-31
2009-12-31 $9
2009-09-30 $16
2009-06-30 $15
2009-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00